Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAP3 carbon dioxide for acute migraine
2004-003973-10Phase 2Completed
- Sponsor
- Capnia, Inc.
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Carbon dioxide in migraine, sponsored by Capnia, Inc. Primary endpoint: Pain-free status at multiple time points. Started May 2005; status: completed.
02
Drugs
Carbon dioxide
03
Conditions
migraine
Beyond the preview
Go deeper on 2004-003973-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003973-10.